Matthew Korenberg
Overview
Matthew Korenberg received an average of $3M in total compensation, including $400K in salary, at Ligand Pharmaceuticals from 2015 to 2021.
2021Ligand PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2020Ligand PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2019Ligand PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2018Ligand PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2017Ligand PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2016Ligand PharmaceuticalsVice President, Finance and Chief Financial Officer
2015Ligand PharmaceuticalsVice President, Finance and Chief Financial Officer
Source: SEC filings on April 22, 2022, November 12, 2020, April 24, 2020, April 30, 2018, and April 14, 2017.
Related executives
We found eight more executives who work or worked at Ligand Pharmaceuticals.
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
Charles Berkman
Ligand Pharmaceuticals
General Counsel
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
Melanie Herman
Ligand Pharmaceuticals
Chief Financial Officer
John Sharp
Ligand Pharmaceuticals
Chief Financial Officer
Martin Meglasson
Ligand Pharmaceuticals
Vice President, Discovery Research
Zofia Dziewanowska
Ligand Pharmaceuticals